Engineering increased stability in the antimicrobial peptide pediocin PA-1.
about
Development of innovative pediocin PA-1 by DNA shuffling among class IIa bacteriocinsSynthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin PDetermination of essential and variable residues in pediocin PA-1 by NNK scanningA non-pediocin low molecular weight antimicrobial peptide produced by Pediococcus pentosaceus strain IE-3 shows increased activity under reducing environment.Cloning strategies for heterologous expression of the bacteriocin enterocin A by Lactobacillus sakei Lb790, Lb. plantarum NC8 and Lb. casei CECT475.The continuing story of class IIa bacteriocinsApproaches for reducing Salmonella in pork production.Rapid two-step procedure for large-scale purification of pediocin-like bacteriocins and other cationic antimicrobial peptides from complex culture medium.Development of Class IIa Bacteriocins as Therapeutic Agents.Use of the yeast Pichia pastoris as an expression host for secretion of enterocin L50, a leaderless two-peptide (L50A and L50B) bacteriocin from Enterococcus faecium L50Novel expression system for large-scale production and purification of recombinant class IIa bacteriocins and its application to piscicolin 126.Bioengineering: a bacteriocin perspective.Development of bacteriocinogenic strains of Saccharomyces cerevisiae heterologously expressing and secreting the leaderless enterocin L50 peptides L50A and L50B from Enterococcus faecium L50.Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli.Production of active pediocin PA-1 in Escherichia coli using a thioredoxin gene fusion expression approach: cloning, expression, purification, and characterization.Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.Improving catalytic activity of the Baeyer-Villiger monooxygenase-based Escherichia coli biocatalysts for the overproduction of (Z)-11-(heptanoyloxy)undec-9-enoic acid from ricinoleic acid.Discovery of Peptide Drugs from Natural Sources
P2860
Q33289369-8A76B832-5911-43F0-BAA5-5F1CF596F1DDQ34055252-62733001-586E-4733-AA48-09849D8962EFQ34431234-19F5B06D-61B9-4DE5-8B09-AF04981D227DQ34570580-72A1EB73-ED98-44D6-83A6-98B95A816565Q35809367-024E4E67-6BC9-4B4B-9EE5-610C79F611B8Q36499681-F2B536B6-7C25-4725-8E74-F8D6AD996F7FQ37017500-7BBB6917-0A76-4A84-9559-1F86DA533A9BQ39649945-54965FCA-B1D3-49C3-B87C-9C31ECAC9513Q39751193-DED16B98-F8F8-487D-A689-1C6B294B4A9EQ40526714-8FBFFA0B-E4D5-4FE2-BC9F-CEDFD7D38A5BQ40937527-F3DD8C42-0B2F-4313-8851-B06A363DCCF9Q41476222-726036D2-F1D1-48B3-82AF-57EDE3C67D3FQ41833857-FE14754F-6DD4-46BE-81FD-0057E768C732Q42060877-3577FB6D-BFB6-481C-B510-40178803CAFBQ42212247-90B9FBB0-3E3C-4A80-89F2-342E4B6A5385Q53515316-84F27F3F-91E8-4ABE-8881-219D24045715Q55383276-46350138-D200-44D2-B6BA-5AE44DAB06BCQ55534837-F2C3FC05-FEAA-4A97-AC3A-09058358FBFAQ59286551-76A59426-0465-4ADB-97A0-9340D2825B75
P2860
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
@en
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
@nl
type
label
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
@en
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
@nl
prefLabel
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
@en
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
@nl
P2093
P2860
P1476
Engineering increased stability in the antimicrobial peptide pediocin PA-1.
@en
P2093
J Nissen-Meyer
P2860
P304
P356
10.1128/AEM.66.11.4798-4802.2000
P407
P577
2000-11-01T00:00:00Z